Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host

Frontiers in Cellular and Infection Microbiology(2023)10.3389/fcimb.2023.1274175Source: DataRank Database

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host is a research paper published in Frontiers in Cellular and Infection Microbiology (2023). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 5.01)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

M. Nurul Islam ORCID,John T. Belisle ORCID,Jordi B. Torrelles ORCID,Alyssa Schami ORCID

Live enrichment

PubMed:38029252 PMC:PMC10664572 OpenAlex:https://openalex.org/W4388100197

National Institute of Allergy and Infectious Diseases

Grant: R01 AI-146340, P30-AI168439

Texas Biomedical Research Institute

Grant: Douglass Graduate Student Fellowship

NIAID NIH HHS

Grant: P30 AI168439

NIAID NIH HHS

Grant: R01 AI146340

National Institutes of Health

Grant: 7R01AI146340-04

The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis

National Institutes of Health

Grant: 1P30AI168439-01

Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)

FWCI

5.01

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fcimb.2023.1274175/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2023.1274175/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2023.1274175/full

journalhttps://doi.org/10.3389/fcimb.2023.1274175

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38029252

Fields of Study

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisCancer therapeutics and mechanisms0301 basic medicine0303 health sciences03 medical and health sciences0302 clinical medicineHumansMycobacterium tuberculosisAntitubercular AgentsTuberculosisTuberculosis, Multidrug-ResistantGlobal HealthDrug Resistance, Multiple, Bacterial

MeSH Terms

Antitubercular AgentsHumansMycobacterium tuberculosisTuberculosisGlobal HealthTuberculosis, Multidrug-ResistantDrug Resistance, Multiple, Bacterial

Keywords

TuberculosisMycobacterium tuberculosisDrug resistancePandemicDrugSubclinical infectionDiseaseVirologyMedicineBiologyMicrobiologyIntensive care medicineInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)PharmacologyCell Envelope LipidsM.Tb-Host InteractionsAntitubercular AgentsGlobal HealthQR1-502Cellular and Infection MicrobiologyDrug Resistance, Multiple, BacterialTuberculosis, Multidrug-ResistantHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being